Showing results (501-510 of 533) with videos related to

Sort By:
Pageof 54
Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2024
Clinical signatures of genetic epilepsies precede diagnosis in electronic medical records of 32,000 individualsPeter D Galer, Shridhar Parthasarathy, Julie Xian, et al.
Kidney International Reports|March 14, 2024
Novel Colorimetric and Light Scatter Methods to Identify and Manage Peritoneal Dialysis-Associated Peritonitis at the Point-of-CareNishal Govindji-Bhatt, Stephnie M Kennedy, Michael G Barker, et al.
Nature Reviews. Drug Discovery|March 5, 2016
Altering the course of schizophrenia: progress and perspectivesMark J Millan, Annie Andrieux, George Bartzokis, et al.
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
BMC Nephrology|December 8, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemicMichelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, et al.
Carcinogenesis|June 25, 2015
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingWilhelm Engström, Philippa Darbre, Staffan Eriksson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 2, 2026
ACMG/AMP variant classification specifications from the ClinGen Epilepsy Sodium Channel Variant Curation Expert PanelLacey Smith, Emily Bonkowski, Anna Prentice, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
Pageof 54